Concepedia

Hoi‐Kei Lon

HL

Statistics

Publications

7

Citations

260

H-Index

7

Active since

2011

Affiliations

University at Buffalo, State University of New York(Current)

Hoi‐Kei Lon is an author at University at Buffalo, State University of New York specializing in pharmacokinetics, pharmacology, and inflammatory arthritis.

Publications per year

2011–2024

7

Publications

7

Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial

Günter U. Höglinger, Irene Litvan, Nuno Mendonça et al. · The Lancet Neurology · 2021 · 138 citations · Full text

, , +4

Pharmacokinetic-Pharmacodynamic Disease Progression Model for Effect of Etanercept in Lewis Rats with Collagen-Induced Arthritis

Hoi‐Kei Lon, Dongyang Liu, Qi Zhang et al. · Pharmaceutical Research · 2011 · 38 citations

, , +16

Pharmacokinetics, pharmacodynamics and toxicities of methotrexate in healthy and collagen‐induced arthritic rats

Dongyang Liu, Hoi‐Kei Lon, Yanlin Wang et al. · Biopharmaceutics & Drug Disposition · 2013 · 26 citations · Full text

, , +14

Population pharmacokinetic–pharmacodynamic–disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritis

Dongyang Liu, Hoi‐Kei Lon, Debra C. DuBois et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2011 · 22 citations · Full text

, , +14

Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approach

Hoi‐Kei Lon, Dongyang Liu, Debra C. DuBois et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2013 · 14 citations · Full text

, , +14

1–5 of 7